In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Opko Health

http://www.opko.com

Latest From Opko Health

Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else

Almost 80% of novel agent submissions from the biggest companies were approved in recent years, compared with a 60% approval rate for the rest of the industry, according to a Pink Sheet analysis of FDA approval decisions since 2021.

US FDA Performance Tracker Drug Review

Biopharma Industry Sharply Divided Over Supreme Court Antibody Patent Brawl

Big biologic makers line up on opposite sides of dispute between Amgen and Sanofi over whether Amgen’s Repatha patents cover analogous antibodies with the same functional characteristics.

Biologics Intellectual Property

Scrip Asks...What Does 2023 Hold For Biopharma? Part 2: M&A And Partnering

Deal-making between big pharma and biotech looks set to rise with a looming patent cliff increasing the need for the former to replenish its pipelines. Meanwhile, biotechs need partners to help them advance amid the ongoing big freeze on raising cash on public markets.

Scrip Asks M & A

Dealmaking Quarterly Statistics, Q2 2022

During Q2, biopharma merger and acquisition value reached $25.4bn and drew in $27.3bn in potential deal value from alliances. Device company M&A values reached $2.7bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $534.3m.

Commercial Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
    • Nutraceuticals
    • Vaccines
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • Laboratory Testing Services
    • Anatomical Pathology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
    • Therapeutic Drug Monitoring
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Pharmacogenetics-Pharmacogenomics
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • ALS Distribuidora Limitada
    • Bio-Reference Laboratories, Inc.
    • Claros Diagnostics Inc.
    • CURNA, Inc.
    • Cytochroma, Inc.
    • EirGen Pharma, Ltd.
    • eXegenics, Inc.
    • GeneDX
    • Modigene
    • Inspiro Medical Ltd.
    • OURLab
    • PROLOR Biotech, Inc.
    • Prost-Data, Inc.
    • Silcon Comércio
    • Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos Ltda.
    • Transition Therapeutics Inc.
    • Waratah Pharmaceuticals Inc.
UsernamePublicRestriction

Register